Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Stem cells are in deep skin layers, while differentiating cells are in shallow layers.

M50054 may help treat hepatitis and hair loss from chemotherapy.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Tislelizumab can cause cutaneous lupus erythematosus.

ILC1 cells contribute to hair loss in alopecia areata.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Certain immune cells, when activated by specific signals, can encourage hair growth.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

The tool iCOUNT helps understand how stem cells divide and affect tissue development and repair.

BCC can protect heart cells from damage caused by oxidative stress.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

Hair follicle cells help maintain and support stem cells and blood cell formation.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Telocytes might help with skin repair and regeneration.

Immature hair cells can grow and change into different types of hair cells over time.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Controlling Tslp can improve health in AEC syndrome patients.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.